Catalyst Wire Dossier Catalyst Wire Dossier

TQB3455 Tablets

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3455 Tablets, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies [Phase 1]

See pricing